Study Overview
This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.
Description
The VOYAGER study is a primary data collection, non-interventional, prospective, multinational, multicenter study. It is designed to collect real-world, long-term data to explore long-term effectiveness, safety, clinical insights, treatment patterns, and factors driving the treatment decisions among patients being treated with specified Roche ophthalmology products in approved retinal indications (Faricimab for neovascular age-related macular degeneration \[nAMD\], diabetic macular edema \[DME\], and retinal vein occlusion; Port Delivery System with Ranibizumab for nAMD) in routine clinical practice. This study will not provide or make recommendations on use of any products including Roche products; treatment decisions will be determined by the treating physician and must be made independently to the decision to participate in this study. Participation in this study will not change or influence a patient's standard of care in any way.
Official Title
Real-World, Long-Term Data Collection to Gain Clinical Insights Into Roche Ophthalmology Products (VOYAGER STUDY)
Quick Facts
Study Start:2022-11-21
Study Completion:2027-11-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
| Inclusion Criteria | Exclusion Criteria |
|---|
| |
Contacts and Locations
Study Locations (Sites)
Retinal Research Institute, LLC
Phoenix, Arizona, 85014
United States
California Eye Specialists Medical group Inc.
Pasadena, California, 91107
United States
Retinal Consultants Medical Group
Sacramento, California, 95825
United States
Advanced Research
Coral Springs, Florida, 33067
United States
Retina Specialty Institute
Pensacola, Florida, 32503
United States
University Retina and Macula Associates, PC
Lemont, Illinois, 60439
United States
Springfield Clinic, Llp
Springfield, Illinois, 62703
United States
Retina Associates of Kentucky
Lexington, Kentucky, 40509
United States
Cumberland Valley Retina Consultants PC
Hagerstown, Maryland, 21740
United States
Associated Retinal Consultants PC
Royal Oak, Michigan, 48073
United States
Erie Retinal Surgery
Erie, Pennsylvania, 16507
United States
Tennessee Retina PC
Nashville, Tennessee, 37203
United States
Brown Retina Institute
San Antonio, Texas, 78251-4551
United States
Retina Center of Texas
Southlake, Texas, 76092-1352
United States
University of Utah, John Moran Eye Center
Salt Lake City, Utah, 84132
United States
Piedmont Eye Center
Lynchburg, Virginia, 24502
United States
Wagner Macula and Retina Center
Norfolk, Virginia, 23502-3933
United States
Spokane Eye Clinical Research
Spokane, Washington, 99204
United States
Collaborators and Investigators
Sponsor: Hoffmann-La Roche
- Clinical Trials, STUDY_DIRECTOR, Hoffmann-La Roche
Study Record Dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
Study Start Date2022-11-21
Study Completion Date2027-11-30
Study Record Updates
Study Start Date2022-11-21
Study Completion Date2027-11-30
Terms related to this study
Additional Relevant MeSH Terms
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
- Retinal Vein Occlusion
- Branch Retinal Vein Occlusion
- Central Retinal Vein Occlusion
- Hemi-retinal Vein Occlusion